<VariationArchive VariationID="2691741" VariationName="NM_001128203.2(PLAAT3):c.286dup (p.Ala96fs)" VariationType="Duplication" Accession="VCV002691741" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2024-02-04" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2852763" VariationID="2691741">
      <GeneList>
        <Gene Symbol="PLAAT3" FullName="phospholipase A and acyltransferase 3" GeneID="11145" HGNC_ID="HGNC:17825" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q12.3-13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="63574462" stop="63616927" display_start="63574462" display_stop="63616927" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="63341933" stop="63381940" display_start="63341933" display_stop="63381940" Strand="-" />
          </Location>
          <OMIM>613867</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001128203.2(PLAAT3):c.286dup (p.Ala96fs)</Name>
      <CanonicalSPDI>NC_000011.10:63590200:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="63590200" stop="63590201" display_start="63590200" display_stop="63590201" variantLength="1" positionVCF="63590200" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="63357672" stop="63357673" display_start="63357672" display_stop="63357673" variantLength="1" positionVCF="63357672" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>A96fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.63590203dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.63590203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.63357675dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.63357675dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128203.2" sequenceAccession="NM_001128203" sequenceVersion="2" change="c.286dup" MANESelect="true">
            <Expression>NM_001128203.2:c.286dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121675.1" sequenceAccession="NP_001121675" sequenceVersion="1" change="p.Ala96fs">
            <Expression>NP_001121675.1:p.Ala96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007069.3" sequenceAccession="NM_007069" sequenceVersion="3" change="c.286dup">
            <Expression>NM_007069.3:c.286dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009000.2" sequenceAccession="NP_009000" sequenceVersion="2" change="p.Ala96fs">
            <Expression>NP_009000.2:p.Ala96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128203.2" sequenceAccession="NM_001128203" sequenceVersion="2" change="c.286dupG" MANESelect="true">
            <Expression>NM_001128203.2:c.286dupG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613867.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001128203.2(PLAAT3):c.286dup (p.Ala96fs) AND Lipodystrophy, familial partial, type 9" Accession="RCV003493366" Version="2">
        <ClassifiedConditionList TraitSetID="93232">
          <ClassifiedCondition DB="MedGen" ID="C5882746">Lipodystrophy, familial partial, type 9</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-03-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-04" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">37919452</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="93232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="72521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lipodystrophy, familial partial, type 9</ElementValue>
                <XRef ID="MONDO:0958034" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPLD9</ElementValue>
                <XRef Type="MIM" ID="620683" DB="OMIM" />
              </Symbol>
              <XRef ID="C5882746" DB="MedGen" />
              <XRef ID="MONDO:0958034" DB="MONDO" />
              <XRef Type="MIM" ID="620683" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7918550" SubmissionDate="2024-01-25" DateLastUpdated="2024-03-10" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="613867.0002_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9" title="PLAAT3, 1-BP DUP, 286G_LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9" />
        <ClinVarAccession Accession="SCV004242160" DateUpdated="2024-03-10" DateCreated="2024-02-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 42-year-old woman (P4), born of consanguineous Algerian parents (family 2), with familial partial lipodystrophy type 9 (FPLD9; 620683), Schuermans et al. (2023) identified a homozygous 1-bp duplication (c.286dupG, NM_001128203.2) in exon 3 of the PLAAT3 gene, predicted to result in a frameshift and premature termination (Ala96GlyfsTer16). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The mutation was predicted to result in nonsense-mediated mRNA decay and a loss of function. Subcutaneous white adipose tissue (WAT) from the patient showed larger adipocytes compared to controls, and lipidomic analysis showed increased levels of AA-containing phospholipids lysophosphatidylcholine (LPC) and lysophosphatidylethanolamine (LPE) compared to controls, consistent with decreased activity of PLA2 (see, e.g., 172410).</Attribute>
              <Citation>
                <CitationText>Schuermans, N., El Chehadeh, S., Hemelsoet, D., Gautheron, J., Vantyghem, M.-C., Nouioua, S., Tazir, M., Vigouroux, C., Auclair, M., Bogaert, E., Dufour, S., Okawa, F., and 24 others Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPAR-gamma signaling. Nature Genet. 55: 1929-1940, 2023.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="620683" Type="MIM" />
              <XRef DB="OMIM" ID="172410" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLAAT3" />
          </GeneList>
          <Name>PLAAT3, 1-BP DUP, 286G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 286G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613867.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7918550" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 9" MappingRef="Preferred">
        <MedGen CUI="C5882746" Name="Lipodystrophy, familial partial, type 9" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

